New markers for diabetic kidney disease in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether certain proteins in your blood can help detect kidney damage earlier in people with type 2 diabetes. It aims to find better ways to monitor kidney health and potentially prevent or delay diabetic kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 2 diabetes.
- You do not have other kidney diseases.
- Your kidney function (measured by a blood test called eGFR) is above 30.
- You do not have an active infection, recent heart or brain problem, or diabetic emergency.
- You do not have cancer, blood disorders, or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This study looks at certain blood markers (immune system and platelets) in people with diabetic kidney disease compared to healthy people. It may help doctors better understand and manage diabetes-related kidney damage.
This study is looking at two substances in the blood of people with diabetic nephropathy to see if they can help doctors understand or track kidney disease. The goal is to improve care for people with diabetes-related kidney problems.
This study is testing two new blood tests (cathepsin S and chromogranin A) to see if they can detect early kidney damage in people with type 2 diabetes. It may help doctors find kidney problems sooner.
This trial is developing and checking a new technique to detect early diabetic nephropathy, which means early damage to the kidneys caused by diabetes. It may help people catch kidney problems sooner, so treatment can start earlier.
Hear when a new Diabetic Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.